Prevalence, characteristics and prognostic value during long-term follow-up of nonsustained ventricular tachycardia after myocardial infarction in the thrombolytic era
Stefan H. Hohnloser, MD, FACCa,
Thomas Klingenheben, MDa,
Markus Zabel, MDa,
Matthias Schöpperl, MDa and
Oliver Mauß, MSca
a Division of Cardiology, Department of Medicine, J.W. Goethe University, Frankfurt, Germany
View larger version (11K):
[in a new window]
|
Figure 1 Distribution of maximal length of nonsustained VT episodes.
|
|
View larger version (15K):
[in a new window]
|
Figure 2 Kaplan-Meier event probabilities for patients with a LVEF above and below 35%, considering the composite primary study end point.
|
|
View larger version (16K):
[in a new window]
|
Figure 3 Kaplan-Meier event probabilities for patients with a patent, compared with those with an occluded infarct-related, artery considering the composite primary study end point.
|
|
View larger version (23K):
[in a new window]
|
Figure 4 Top, Kaplan-Meier event probabilities for patients with a depressed, compared with those with preserved, HRV considering the composite primary study end point. Bottom, Kaplan-Meier event probabilities for patients with a depressed, compared with those with preserved, HRV considering the secondary study end point.
|
|
View larger version (23K):
[in a new window]
|
Figure 5 Top, Kaplan-Meier event probabilities for patients with, compared with those without, nonsustained VT considering the composite primary study end point. Bottom, Kaplan-Meier event probabilities for patients with, compared with those without, nonsustained; VT considering the secondary study end point. Note that there is no predictive value of nonsustained VT concerning sudden death or arrhythmic events.
|
|
|
